Nicoletti, PaolaDellinger, AndrewLi, Yi-JuBarnhart, HuimanPhillips, ElizabethChalasani, NagaDrug Induced Liver Injury Network (DILIN) investigators2025-03-032025-03-032024Nicoletti P, Dellinger A, Li YJ, et al. HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans. Am J Gastroenterol. 2024;119(1):200-202. doi:10.14309/ajg.0000000000002454https://hdl.handle.net/1805/46168Introduction: To investigate human leukocyte antigen alleles associated with liver injury due to antiepileptic drugs (AEDs) in African Americans (AA). Methods: In this study, 21 AA with AED drug-induced liver injury (DILI), 176 AA with DILI due to non-AEDs, and 5816 AA population controls were included. Results: HLA-B*53:01 was significantly associated with aromatic AED-DILI (odds ratio: 4.52, 95% confidence interval: 2.42-8.44, P = 1.46 × 10 -5 ). Phenytoin DILI showed the strongest association with HLA-B*53:01 (odds ratio: 9.17; 95% confidence interval: 3.61-23.28, P = 1.1 × 10 -5 ). The HLA-B*53:01 allele was carried by 8 of 9 AA phenytoin DILI cases. Discussion: HLA-B*53:01 is a significant risk factor of liver injury due to antiepileptics, particularly phenytoin, in AA.en-USPublisher PolicyAnticonvulsantsChemical and drug induced liver injuryPhenytoinArticle